| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c51ea0deadb0c18cfc9815d86bc9507e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cea72e2de3c0219165474e54e9842d16 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-08 |
| filingDate |
1998-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f7466570762023b00a5eca475e965ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87cc736bc09e38a0b6befd09c7fa4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_940aaf20cf7449834b3c6cbddda30426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e696f92ec35a67ec8561ade0ab2813d |
| publicationDate |
1998-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NO-981093-L |
| titleOfInvention |
2- [2- [2- (2-hydroxyethyl) amino] ethyl | -5- ££ 2-methylamino) ethyl | amino | -indazolo £ 4,3-gh |
| abstract |
The present invention relates to 2- [2 - [(2-hydroxyethyl) amino] ethyl] -5 - [[2-methylamino) ethyl] amino] indazolo [4,3-gh] isoquinolin-6 (2H) -one wherein the pharmaceutically acceptable acid addition salts thereof, of formula (I). This compound has shown a high antitumor activity. |
| priorityDate |
1995-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |